Edition:
India

Episurf Medical AB (EPISb.ST)

EPISb.ST on Stockholm Stock Exchange

2.26SEK
9:30pm IST
Change (% chg)

-0.02kr (-0.88%)
Prev Close
2.28kr
Open
2.25kr
Day's High
2.37kr
Day's Low
2.15kr
Volume
2,018,549
Avg. Vol
1,295,383
52-wk High
2.83kr
52-wk Low
0.94kr

Latest Key Developments (Source: Significant Developments)

Episurf Medical: Positive Results From Follow-Up Of First Episealer Knee Patients
Tuesday, 8 Sep 2020 

Sept 8 (Reuters) - Episurf Medical AB ::POSITIVE RESULTS FROM 5-7 YEARS' FOLLOW-UP OF THE FIRST EPISEALER® KNEE PATIENTS IN A SWEDISH MULTICENTRE CLINICAL TRIAL.STUDY NOW CONCLUDES THAT POSITIVE RESULTS AT 24 MONTHS' FOLLOW-UP PREVIOUSLY PRESENTED, REMAIN UNCHANGED AT AN AVERAGE FOLLOW-UP TIME OF 75 MONTHS, AND THAT NO IMPLANT REVISIONS HAVE BEEN PERFORMED..  Full Article

Episurf Medical: Episealer Implants Approved For Sale In France
Friday, 14 Aug 2020 

Aug 14 (Reuters) - Episurf Medical AB ::EPISEALER® IMPLANTS APPROVED FOR SALE IN FRANCE.EPISURF MEDICAL HAS FURTHER RECEIVED REGULATORY APPROVAL FOR EPISEALER® TALUS IN ISRAEL AND IS EXPECTING APPROVAL FOR EPISEALER® TALUS IN POLAND SHORTLY..  Full Article

Episurf Q2 Loss Narrows To SEK 14.4 Mln
Friday, 17 Jul 2020 

July 17 (Reuters) - Episurf Medical AB ::Q2 ORDER BACKLOG SEK 1.2 MILLION VERSUS SEK 0.7 MILLION YEAR AGO.Q2 GROSS ORDER INTAKE AMOUNTED TO SEK 1.0M (1.3).Q2 NET SALES SEK 0.6 MILLION VERSUS SEK 1.1 MILLION YEAR AGO.Q2 LOSS FOR PERIOD AMOUNTED TO SEK -14.4M (-18.9).  Full Article

Episurf Medical Gets New European Patent Approval
Tuesday, 14 Jul 2020 

July 14 (Reuters) - Episurf Medical AB ::NEW EUROPEAN PATENT APPROVAL FOR EPISURF MEDICAL.EUROPEAN PATENT OFFICE EPO HAS ANNOUNCED ITS INTENTION TO GRANT ANOTHER EUROPEAN PATENT FOR EPISURF MEDICAL (NASDAQ: EPIS B).PATENT, ENTITLED "DESIGN METHOD OF A RIG", IS WITHIN AREA OF INDIVIDUALISED SURGICAL INSTRUMENTS RELATED TO COMPANY'S EPISEALER® IMPLANTS.  Full Article

Episurf To Get New Patent In Sweden
Monday, 22 Jun 2020 

June 23(Reuters) - Episurf Medical AB ::SAID ON MONDAY SWEDISH PATENT OFFICE PRV ANNOUNCED INTENTION TO GRANT ANOTHER SWEDISH PATENT FOR EPISURF .PATENT IS WITHIN AREA OF JOINT IMPLANT MATERIALS AND IMPLANT FEATURES..  Full Article

Episurf Medical Gets New Japanese Patent Approval
Thursday, 18 Jun 2020 

June 18 (Reuters) - Episurf Medical AB ::NEW JAPANESE PATENT APPROVAL FOR EPISURF MEDICAL.PATENT, ENTITLED "SYSTEM AND METHOD FOR CREATING A DECISION SUPPORT MATERIAL INDICATING DAMAGE TO AN ANATOMICAL JOINT", IS WITHIN AREA OF 3D-BASED ASSESSMENT OF JOINT LESIONS.  Full Article

Episurf Medical: New European Patent Approval
Wednesday, 10 Jun 2020 

June 10 (Reuters) - Episurf Medical AB ::NEW EUROPEAN PATENT APPROVAL FOR EPISURF MEDICAL.EUROPEAN PATENT OFFICE EPO HAS ANNOUNCED ITS INTENTION TO GRANT ANOTHER EUROPEAN PATENT FOR EPISURF MEDICAL.  Full Article

Episurf Medical: New European Patent Approval
Monday, 8 Jun 2020 

June 8 (Reuters) - Episurf Medical AB ::NEW EUROPEAN PATENT APPROVAL FOR EPISURF MEDICAL.EUROPEAN PATENT OFFICE EPO HAS ANNOUNCED ITS INTENTION TO GRANT ANOTHER EUROPEAN PATENT FOR EPISURF MEDICAL.  Full Article

First Korean Patent Approval For Episurf Medical
Thursday, 28 May 2020 

May 28 (Reuters) - Episurf Medical AB ::FIRST KOREAN PATENT APPROVAL FOR EPISURF MEDICAL.GETS NOTICE OF ALLOWANCE FROM KOREAN INTELLECTUAL PROPERTY OFFICE (KIPO), IMPLYING COMPANY'S FIRST PATENT APPROVAL IN KOREA..  Full Article

Episurf Medical Q1 Loss For Period Widens To SEK 17.9 Mln
Friday, 24 Apr 2020 

April 24 (Reuters) - Episurf Medical AB ::Q1 GROSS ORDER INTAKE AMOUNTED TO SEK 1.6M (1.1).Q1 ORDER BACKLOG AMOUNTED TO SEK 1.0M (1.0).Q1 GROUP NET SALES INCREASED BY 3.9% TO SEK 1.5M (1.4)."EVEN THOUGH HALT IN ELECTIVE SURGERIES NEGATIVELY IMPACTED ABOUT ONE-THIRD OF QUARTER, WE POSTED A 45% GROWTH IN OUR ORDER-INTAKE" CEO.Q1 LOSS FOR PERIOD AMOUNTED TO SEK -17.9M (-14.6).  Full Article

BRIEF-Episurf Medical Becomes Approved Supplier To BMI Healthcare

* EPISURF MEDICAL APPROVED SUPPLIER TO BMI HEALTHCARE, THE LARGEST INDEPENDENT HOSPITAL PROVIDER IN THE UK